Two Sigma Advisers »

Dianthus Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $907k 22k 41.21

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Micron Technology (MU)
Palantir Technologies Cl A (PLTR)
Charles Schwab Corporation (SCHW)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Intuitive Surgical Com New (ISRG)
Boston Scientific Corporation (BSX)
Lockheed Martin Corporation (LMT)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Advisers

Top funds holding Dianthus Therapeutics

FMR
Wellington Management Company
Octagon Capital Advisors
Fairmount Funds Management
Avidity Partners Management
Vanguard Group
BlackRock
TCG Crossover Management
RA Capital Management
State Street Corporation
Braidwell
Point72 Asset Management
Citadel Advisors
Marshall Wace
Polar Capital Holdings

View all funds holding Dianthus Therapeutics